May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Expression of Cell Cycle–Related Proteins( Ki–67, PCNA, Cyclin E, CDK2) and Apoptosis Markers( Active Caspase–3, p85–PARP) in Vitreoretinal Disorders( PVR, PDR, Macular Pucker)
Author Affiliations & Notes
  • X. Zhang
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
    Ophthalmology, Columbia University, New York, NY
  • G.R. Barile
    Ophthalmology, Columbia University, New York, NY
  • L. Li
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • H. Chen
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • X. Zhu
    Ophthalmology, Beijing Tongren Hospital, Beijing, China
  • S. Pachydaki
    Ophthalmology, Columbia University, New York, NY
  • W.M. Schiff
    Ophthalmology, Columbia University, New York, NY
  • J.R. Sparrow
    Ophthalmology, Columbia University, New York, NY
  • S. Chang
    Ophthalmology, Columbia University, New York, NY
  • Footnotes
    Commercial Relationships  X. Zhang, None; G.R. Barile, None; L. Li, None; H. Chen, None; X. Zhu, None; S. Pachydaki, None; W.M. Schiff, None; J.R. Sparrow, None; S. Chang, None.
  • Footnotes
    Support  Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 5128. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X. Zhang, G.R. Barile, L. Li, H. Chen, X. Zhu, S. Pachydaki, W.M. Schiff, J.R. Sparrow, S. Chang; Expression of Cell Cycle–Related Proteins( Ki–67, PCNA, Cyclin E, CDK2) and Apoptosis Markers( Active Caspase–3, p85–PARP) in Vitreoretinal Disorders( PVR, PDR, Macular Pucker) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):5128.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Inhibition of cell proliferation and induction of apoptosis have been implicated as potential therapeutic approaches for a variety of proliferative diseases such as proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy(PDR) .The objectives of the present study are to assess the incidence of cell proliferation and apoptosis and further investigate the potential involvement of key regulators of cell cycle and apoptosis in epiretinal membranes(ERMs). Methods: ERMs were obtained from 39 eyes of 39 patients who underwent vitrectomy surgery for PVR, PDR and macular pucker(MP). Cell proliferation was evaluated by Ki–67 and PCNA (proliferation cell nuclear antigen) immunochemistry staining. Apoptosis was assessed by TUNEL assay. The expression of cyclin E, CDK2 (cyclin–dependent kinase 2),caspase–3 and PARP(poly–ADP–ribose–polymerase) were detected using specific antibodies for cyclin E(HE 12), CDK2(M2), activated caspase–3 and p85 fragment of PARP. Cytokeratin and active caspase–3/PARP double staining was applied to localize RPE cells undergoing apoptosis. Results: The expression of Ki–67 and PCNA was detected in all the patients and appeared to be correlated with cyclin E/ CDK2 expression. There were no significant differences in proliferative index(PI) between PVR and PDR(P=0.1882), PVR and MP (P=0.5440), PDR and MP(P=0.8210). The Ki–67 and PCNA expression occurs in RPE cells and/or glial cells. Apoptotic nuclei was correlated with the increased expression of activated caspase–3 and the p85 fragment of PARP. Most apoptotic cells appeared to be RPE cells. Apoptotic nuclei appeared to be presented more frequently in longstanding ERMs. However, no significant differences in apoptotic index(AI) were found between PVR and PDR(P=0.4178), PDR and MP(P=0.4876), PVR and MP(P=0.2544). Conclusions: This study supports the notion that cell proliferation and apoptosis are key regulatory mechanisms of specific cell population of ERMs in patients with PVR, PDR and macular pucker. Inhibition of cell cycle G1 regulators and induction of apoptotic regulators such as caspase–3 activation may serve therapeutic interventions for proliferative retinal disorders.

Keywords: proliferation • cell death/apoptosis • proliferative vitreoretinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×